Literature DB >> 16779965

Permeation peptide conjugates for in vivo molecular imaging applications.

Kristin E Bullok1, Seth T Gammon, Stefania Violini, Andrew M Prantner, Victor M Villalobos, Vijay Sharma, David Piwnica-Worms.   

Abstract

Rapid and efficient delivery of imaging probes to the cell interior using permeation peptides has enabled novel applications in molecular imaging. Membrane permeant peptides based on the HIV-1 Tat basic domain sequence, GRKKRRQRRR, labeled with fluorophores and fluorescent proteins for optical imaging or with appropriate peptide-based motifs or macrocycles to chelate metals, such as technetium for nuclear scintigraphy and gadolinium for magnetic resonance imaging, have been synthesized. In addition, iron oxide complexes have been functionalized with the Tat basic domain peptides for magnetic resonance imaging applications. Herein we review current applications of permeation peptides in molecular imaging and factors influencing permeation peptide internalization. These diagnostic agents show concentrative cell accumulation and rapid kinetics and display cytosolic and focal nuclear accumulation in human cells. Combining methods, dual-labeled permeation peptides incorporating fluorescein maleimide and chelated technetium have allowed for both qualitative and quantitative analysis of cellular uptake. Imaging studies in mice following intravenous administration of prototypic diagnostic permeation peptides show rapid whole-body distribution allowing for various molecular imaging applications. Strategies to develop permeation peptides into molecular imaging probes have included incorporation of targeting motifs such as molecular beacons or protease cleavable domains that enable selective retention, activatable fluorescence, or targeted transduction. These novel permeation peptide conjugates maintain rapid translocation across cell membranes into intracellular compartments and have the potential for targeted in vivo applications in molecular imaging and combination therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16779965

Source DB:  PubMed          Journal:  Mol Imaging        ISSN: 1535-3508            Impact factor:   4.488


  20 in total

1.  Toward the Ideal Synthesis and Transformative Therapies: The Roles of Step Economy and Function Oriented Synthesis.

Authors:  Paul A Wender
Journal:  Tetrahedron       Date:  2013-06-07       Impact factor: 2.457

2.  Imaging of molecular signatures of specific structures, functions,and pathological alterations in the lung tissue.Chair's Summary.

Authors:  Vladimir R Muzykantov
Journal:  Proc Am Thorac Soc       Date:  2009-08-15

Review 3.  In situ imaging of metals in cells and tissues.

Authors:  Reagan McRae; Pritha Bagchi; S Sumalekshmy; Christoph J Fahrni
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

4.  NEAR-INFRARED DYES: Probe Development and Applications in Optical Molecular Imaging.

Authors:  Donald D Nolting; John C Gore; Wellington Pham
Journal:  Curr Org Synth       Date:  2011-08       Impact factor: 1.975

5.  Magnetic resonance imaging of cells in experimental disease models.

Authors:  Naser Muja; Jeff W M Bulte
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2009-07       Impact factor: 9.795

6.  Delivery of optical contrast agents using Triton-X100, part 1: reversible permeabilization of live cells for intracellular labeling.

Authors:  Anne L van de Ven; Karen Adler-Storthz; Rebecca Richards-Kortum
Journal:  J Biomed Opt       Date:  2009 Mar-Apr       Impact factor: 3.170

7.  Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model.

Authors:  Edward M Barnett; Xu Zhang; Dustin Maxwell; Qing Chang; David Piwnica-Worms
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-20       Impact factor: 11.205

8.  In vivo and in silico pharmacokinetics and biodistribution of a melanocortin receptor 1 targeted agent in preclinical models of melanoma.

Authors:  Narges K Tafreshi; Ariosto Silva; Veronica C Estrella; Timothy W McCardle; Tingan Chen; Yolaine Jeune-Smith; Mark C Lloyd; Steven A Enkemann; Keiran S M Smalley; Vernon K Sondak; Josef Vagner; David L Morse
Journal:  Mol Pharm       Date:  2013-07-08       Impact factor: 4.939

9.  Fifteen years of cell-penetrating, guanidinium-rich molecular transporters: basic science, research tools, and clinical applications.

Authors:  Erika Geihe Stanzl; Brian M Trantow; Jessica R Vargas; Paul A Wender
Journal:  Acc Chem Res       Date:  2013-05-22       Impact factor: 22.384

10.  Synthesis and characterization of a melanoma-targeted fluorescence imaging probe by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.

Authors:  Narges K Tafreshi; Xuan Huang; Valerie E Moberg; Natalie M Barkey; Vernon K Sondak; Haibin Tian; David L Morse; Josef Vagner
Journal:  Bioconjug Chem       Date:  2012-11-27       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.